Paper

Old drug, new trick: repurposing metformin for gynecologic cancers?

Published Dec 1, 2014 · T. Febbraro, E. Lengyel, Iris L. Romero

Gynecologic oncology

Citations

Influential Citations

Abstract

Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Study Snapshot

Key takeawayMetformin use in diabetic women with ovarian and endometrial cancers is associated with reduced risk and improved survival, but its effectiveness in non-diabetic patients remains unclear.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Old drug, new trick: repurposing metformin for gynecologic cancers?

References

Citations